Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
This treatment has been approved for sale to the public.
Sponsor:
Children's Hospital of Philadelphia
Collaborator:
ApoPharma
Information provided by (Responsible Party):
Alan Cohen, Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT00293098
First received: February 16, 2006
Last updated: February 8, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This treatment has been approved for sale to the public. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |